Antares Pharma
ATRS
#6030
Rank
S$1.23 B
Marketcap
S$7.24
Share price
0.00%
Change (1 day)
23.32%
Change (1 year)

P/S ratio for Antares Pharma (ATRS)

P/S ratio at the end of 2021: 3.30

According to Antares Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is N/A. At the end of 2021 the company had a P/S ratio of 3.30.

P/S ratio history for Antares Pharma from 2001 to 2021

PS ratio at the end of each year

Year P/S ratio Change
20213.30-25.78%
20204.45-29.09%
20196.27-8.29%
20186.8419.52%
20175.72-17.35%
20166.9268.62%
20154.10-67.88%
201412.8-54.24%
201327.931.34%
201221.353.62%
201113.823.97%
201011.2-0.53%
200911.2152.52%
20084.44-45.64%
20078.17-45.47%
200615.0-49.99%
200530.050.83%
200419.9268.39%
20035.39376.18%
20021.13-88.31%
20019.69

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
ANI Pharmaceuticals
ANIP
2.22N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
2.61N/A๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical
WST
6.68N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Retractable Technologies
RVP
0.6292N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.36N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1.94N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
5.29N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
15.2N/A๐Ÿ‡บ๐Ÿ‡ธ USA